Big-Cap Biotech Grinding Higher on a Patient CallAmgen Inc.NASDAQ:AMGNDarkFlowSignalsChart reference: daily AMGN, with the $395 strike as the level the calls are working against. Setup thesis. This is a bullish call idea on AMGN that opened in early August and is still carrying. The read was steady institutional buying on a large-cap biotech with a durable chart, the kind of name that rewards patience rather than a race against theta. Big-cap biotech does not need a violent move to pay a well-chosen call; it needs time and a trend, and this one had both. Trade structure. - Vehicle: $395 calls, mid-September expiry. - A core-style swing vehicle with weeks of runway from entry, not a same-week gamble. - Exit discipline: hard stop at negative 50 percent of premium, otherwise ride to expiry, with a profit floor once it runs. What is confirming. The calls sit near +94 percent and peaked close to +140 percent. The move has been a grind rather than a spike, which is exactly the behavior you want from a large-cap continuation. What would invalidate. A break of the recent trend on the daily, or a sector-wide rotation out of biotech, would be the tell to reassess. Outcome (open, carrying). Current near +94 percent, peak near +140 percent. A textbook example of what more time on the clock buys you. How I find these. DarkFlow reads fresh institutional flow off the live tape with multiple confirming signals, then lets the read make the call. Full track record at darkflowsignals.com.